Abstract
Photodynamic therapy (PDT) is a promising alternative approach for improved cancer treatment. In PDT, a photosensitizer (PS) is administered that can be activated by light of a specific wavelength, which causes selective damage to the tumor and its surrounding vasculature. The success of PDT is limited by the difficulty in administering photosensitizers (PSs) with low water solubility, which compromises the clinical use of several molecules. Incorporation of PSs in nanostructured drug delivery systems, such as polymeric nanoparticles (PNPs), solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), gold nanoparticles (AuNPs), hydrogels, liposomes, liquid crystals, dendrimers, and cyclodextrin is a potential strategy to overcome this difficulty. Additionally, nanotechnology-based drug delivery systems may improve the transcytosis of a PS across epithelial and endothelial barriers and afford the simultaneous co-delivery of two or more drugs. Based on this, the application of nanotechnology in medicine may offer numerous exciting possibilities in cancer treatment and improve the efficacy of available therapeutics. Therefore, the aim of this paper is to review nanotechnology-based drug delivery systems for photodynamic therapy of cancer.
Highlights
The combination of dyes and light for treatment of diseases dates back to ancient Egypt, where conditions such as psoriasis and vitiligo were treated with vegetal-derived substances and sunlight [1].it was only in the beginning of 20th century that modern Photodynamic therapy (PDT) began with the discoveries of O
Curcumin is a polyphenolic compound isolated from Curcuma longa L. that has been used for centuries as a medicine, dye, and spice
The following section presents the efforts of researchers to create novel strategies to develop nanotechnology-based drug delivery systems in cancer–PDT
Summary
The combination of dyes and light for treatment of diseases dates back to ancient Egypt, where conditions such as psoriasis and vitiligo were treated with vegetal-derived substances and sunlight [1]. It was only in the beginning of 20th century that modern PDT (photodynamic therapy) began with the discoveries of O. In 1903, von Tappeiner and Jesionek reported the tumoricidal effect of eosin associated with exposure to the white light on skin tumors. They conceived the term “photodynamic action” [3].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.